Central nervous system (CNS) neuroblastoma. A case-based update.
Bianchi F, Tamburrini G, Gessi M, Frassanito P, Massimi L, Caldarelli M.
Childs Nerv Syst. 2018 May;34(5):817-823. doi: 10.1007/s00381-018-3764-3. Epub 2018 Mar 8.
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL.
Pediatr Blood Cancer. 2023 Apr;70(4):e30227. doi: 10.1002/pbc.30227. Epub 2023 Jan 31.
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P, Pasqualini C, Pötschger U, Sangüesa C, Castellani MR, Cañete A, Luksch R, Elliot M, Schreier G, Kropf M, Morgenstern D, Papadakis V, Ash S, Ruud E, Brock P, Wieczorek A, Kogner P, Trahair T, Ambros P, Boterberg T, Castel V, Valteau-Couanet D, Ladenstein R.
Eur J Cancer. 2021 Feb;144:1-8. doi: 10.1016/j.ejca.2020.10.020. Epub 2020 Dec 11.
Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.
Wieczorek A, Stefanowicz J, Hennig M, Adamkiewicz-Drozynska E, Stypinska M, Dembowska-Baginska B, Gamrot Z, Woszczyk M, Geisler J, Szczepanski T, Skoczen S, Ussowicz M, Pogorzala M, Janczar S, Balwierz W.
BMC Cancer. 2022 Jun 25;22(1):701. doi: 10.1186/s12885-022-09776-x.
Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.
Kovalevich J, Langford D.
Methods Mol Biol. 2013;1078:9-21. doi: 10.1007/978-1-62703-640-5_2.
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.
Chan GC, Chan CM.
Biomolecules. 2022 Feb 24;12(3):358. doi: 10.3390/biom12030358.
Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
Aygun N.
Curr Pediatr Rev. 2018;14(2):73-90. doi: 10.2174/1573396314666180129101627.
Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.
Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT.
Front Endocrinol (Lausanne). 2021 Sep 1;12:728088. doi: 10.3389/fendo.2021.728088. eCollection 2021.
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K, Kushner B, Heller G, Cheung NK.
Cancer. 2001 Apr 15;91(8):1510-9.
Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy.
Kramer K, Khan O, Haque S.
J Neurooncol. 2019 Aug;144(1):227-229. doi: 10.1007/s11060-019-03203-1. Epub 2019 Jul 16.
